Quantitative SSTR-PET/CT for Predicting Response and Survival Outcomes in Patients with Pancreatic Neuroendocrine Tumors Receiving CAPTEM. (2023). Radiology and Oncology, 57(4), 436-445. https://www.radioloncol.com/index.php/ro/article/view/4118